The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Acellular Dermal Matrices-Global Market Insights and Sales Trends 2024
Synopsis
Acellular dermal matrix is a biologically derived product, which is devoid of cells. The main components of acellular dermal matrix include collagen and elastic fibers. It has applications in plastic surgery, general surgery, breast reconstruction, cosmetic surgery, wound healing, and others. The matrix is derived from different sources such as human, porcine, bovine, and others.
The global Acellular Dermal Matrices market size is expected to reach US$ 1759.6 million by 2029, growing at a CAGR of 7.9% from 2023 to 2029. The market is mainly driven by the significant applications of Acellular Dermal Matrices in various end use industries. The expanding demands from the Orthopedics, Plastic Surgery, General Surgery and Dental, are propelling Acellular Dermal Matrices market. Human, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Porcine segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Acellular Dermal Matrices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Acellular Dermal Matrices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Acellular Dermal Matrices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Acellular Dermal Matrices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Acellular Dermal Matrices covered in this report include Zimmer Biomet, Stryker Corporation, Staumann, Allergan, Conmed, Integra LifeSciences Corporation, Aziyo Biologics, Hospital Innovations and Medtronic, etc.
The global Acellular Dermal Matrices market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Zimmer Biomet
Stryker Corporation
Staumann
Allergan
Conmed
Integra LifeSciences Corporation
Aziyo Biologics
Hospital Innovations
Medtronic
Synthes
HANS BIOMED
Global Acellular Dermal Matrices market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Acellular Dermal Matrices market, Segment by Type:
Human
Porcine
Bovine
Others
Global Acellular Dermal Matrices market, by Application
Orthopedics
Plastic Surgery
General Surgery
Dental
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Acellular Dermal Matrices companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Acellular dermal matrix is a biologically derived product, which is devoid of cells. The main components of acellular dermal matrix include collagen and elastic fibers. It has applications in plastic surgery, general surgery, breast reconstruction, cosmetic surgery, wound healing, and others. The matrix is derived from different sources such as human, porcine, bovine, and others.
The global Acellular Dermal Matrices market size is expected to reach US$ 1759.6 million by 2029, growing at a CAGR of 7.9% from 2023 to 2029. The market is mainly driven by the significant applications of Acellular Dermal Matrices in various end use industries. The expanding demands from the Orthopedics, Plastic Surgery, General Surgery and Dental, are propelling Acellular Dermal Matrices market. Human, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Porcine segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Acellular Dermal Matrices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Acellular Dermal Matrices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Acellular Dermal Matrices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Acellular Dermal Matrices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Acellular Dermal Matrices covered in this report include Zimmer Biomet, Stryker Corporation, Staumann, Allergan, Conmed, Integra LifeSciences Corporation, Aziyo Biologics, Hospital Innovations and Medtronic, etc.
The global Acellular Dermal Matrices market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Zimmer Biomet
Stryker Corporation
Staumann
Allergan
Conmed
Integra LifeSciences Corporation
Aziyo Biologics
Hospital Innovations
Medtronic
Synthes
HANS BIOMED
Global Acellular Dermal Matrices market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Acellular Dermal Matrices market, Segment by Type:
Human
Porcine
Bovine
Others
Global Acellular Dermal Matrices market, by Application
Orthopedics
Plastic Surgery
General Surgery
Dental
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Acellular Dermal Matrices companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Acellular Dermal Matrices
1.1 Acellular Dermal Matrices Market Overview
1.1.1 Acellular Dermal Matrices Product Scope
1.1.2 Acellular Dermal Matrices Market Status and Outlook
1.2 Global Acellular Dermal Matrices Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Acellular Dermal Matrices Market Size by Region (2018-2029)
1.4 Global Acellular Dermal Matrices Historic Market Size by Region (2018-2023)
1.5 Global Acellular Dermal Matrices Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Acellular Dermal Matrices Market Size (2018-2029)
1.6.1 North America Acellular Dermal Matrices Market Size (2018-2029)
1.6.2 Europe Acellular Dermal Matrices Market Size (2018-2029)
1.6.3 Asia-Pacific Acellular Dermal Matrices Market Size (2018-2029)
1.6.4 Latin America Acellular Dermal Matrices Market Size (2018-2029)
1.6.5 Middle East & Africa Acellular Dermal Matrices Market Size (2018-2029)
2 Acellular Dermal Matrices Market by Type
2.1 Introduction
2.1.1 Human
2.1.2 Porcine
2.1.3 Bovine
2.1.4 Others
2.2 Global Acellular Dermal Matrices Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Acellular Dermal Matrices Historic Market Size by Type (2018-2023)
2.2.2 Global Acellular Dermal Matrices Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Acellular Dermal Matrices Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Acellular Dermal Matrices Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Acellular Dermal Matrices Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Acellular Dermal Matrices Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Acellular Dermal Matrices Revenue Breakdown by Type (2018-2029)
3 Acellular Dermal Matrices Market Overview by Application
3.1 Introduction
3.1.1 Orthopedics
3.1.2 Plastic Surgery
3.1.3 General Surgery
3.1.4 Dental
3.1.5 Others
3.2 Global Acellular Dermal Matrices Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Acellular Dermal Matrices Historic Market Size by Application (2018-2023)
3.2.2 Global Acellular Dermal Matrices Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Acellular Dermal Matrices Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Acellular Dermal Matrices Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Acellular Dermal Matrices Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Acellular Dermal Matrices Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Acellular Dermal Matrices Revenue Breakdown by Application (2018-2029)
4 Acellular Dermal Matrices Competition Analysis by Players
4.1 Global Acellular Dermal Matrices Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Acellular Dermal Matrices as of 2022)
4.3 Date of Key Players Enter into Acellular Dermal Matrices Market
4.4 Global Top Players Acellular Dermal Matrices Headquarters and Area Served
4.5 Key Players Acellular Dermal Matrices Product Solution and Service
4.6 Competitive Status
4.6.1 Acellular Dermal Matrices Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Zimmer Biomet
5.1.1 Zimmer Biomet Profile
5.1.2 Zimmer Biomet Main Business
5.1.3 Zimmer Biomet Acellular Dermal Matrices Products, Services and Solutions
5.1.4 Zimmer Biomet Acellular Dermal Matrices Revenue (US$ Million) & (2018-2023)
5.1.5 Zimmer Biomet Recent Developments
5.2 Stryker Corporation
5.2.1 Stryker Corporation Profile
5.2.2 Stryker Corporation Main Business
5.2.3 Stryker Corporation Acellular Dermal Matrices Products, Services and Solutions
5.2.4 Stryker Corporation Acellular Dermal Matrices Revenue (US$ Million) & (2018-2023)
5.2.5 Stryker Corporation Recent Developments
5.3 Staumann
5.3.1 Staumann Profile
5.3.2 Staumann Main Business
5.3.3 Staumann Acellular Dermal Matrices Products, Services and Solutions
5.3.4 Staumann Acellular Dermal Matrices Revenue (US$ Million) & (2018-2023)
5.3.5 Allergan Recent Developments
5.4 Allergan
5.4.1 Allergan Profile
5.4.2 Allergan Main Business
5.4.3 Allergan Acellular Dermal Matrices Products, Services and Solutions
5.4.4 Allergan Acellular Dermal Matrices Revenue (US$ Million) & (2018-2023)
5.4.5 Allergan Recent Developments
5.5 Conmed
5.5.1 Conmed Profile
5.5.2 Conmed Main Business
5.5.3 Conmed Acellular Dermal Matrices Products, Services and Solutions
5.5.4 Conmed Acellular Dermal Matrices Revenue (US$ Million) & (2018-2023)
5.5.5 Conmed Recent Developments
5.6 Integra LifeSciences Corporation
5.6.1 Integra LifeSciences Corporation Profile
5.6.2 Integra LifeSciences Corporation Main Business
5.6.3 Integra LifeSciences Corporation Acellular Dermal Matrices Products, Services and Solutions
5.6.4 Integra LifeSciences Corporation Acellular Dermal Matrices Revenue (US$ Million) & (2018-2023)
5.6.5 Integra LifeSciences Corporation Recent Developments
5.7 Aziyo Biologics
5.7.1 Aziyo Biologics Profile
5.7.2 Aziyo Biologics Main Business
5.7.3 Aziyo Biologics Acellular Dermal Matrices Products, Services and Solutions
5.7.4 Aziyo Biologics Acellular Dermal Matrices Revenue (US$ Million) & (2018-2023)
5.7.5 Aziyo Biologics Recent Developments
5.8 Hospital Innovations
5.8.1 Hospital Innovations Profile
5.8.2 Hospital Innovations Main Business
5.8.3 Hospital Innovations Acellular Dermal Matrices Products, Services and Solutions
5.8.4 Hospital Innovations Acellular Dermal Matrices Revenue (US$ Million) & (2018-2023)
5.8.5 Hospital Innovations Recent Developments
5.9 Medtronic
5.9.1 Medtronic Profile
5.9.2 Medtronic Main Business
5.9.3 Medtronic Acellular Dermal Matrices Products, Services and Solutions
5.9.4 Medtronic Acellular Dermal Matrices Revenue (US$ Million) & (2018-2023)
5.9.5 Medtronic Recent Developments
5.10 Synthes
5.10.1 Synthes Profile
5.10.2 Synthes Main Business
5.10.3 Synthes Acellular Dermal Matrices Products, Services and Solutions
5.10.4 Synthes Acellular Dermal Matrices Revenue (US$ Million) & (2018-2023)
5.10.5 Synthes Recent Developments
5.11 HANS BIOMED
5.11.1 HANS BIOMED Profile
5.11.2 HANS BIOMED Main Business
5.11.3 HANS BIOMED Acellular Dermal Matrices Products, Services and Solutions
5.11.4 HANS BIOMED Acellular Dermal Matrices Revenue (US$ Million) & (2018-2023)
5.11.5 HANS BIOMED Recent Developments
6 North America
6.1 North America Acellular Dermal Matrices Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Acellular Dermal Matrices Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Acellular Dermal Matrices Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Acellular Dermal Matrices Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Acellular Dermal Matrices Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Acellular Dermal Matrices Market Dynamics
11.1 Acellular Dermal Matrices Industry Trends
11.2 Acellular Dermal Matrices Market Drivers
11.3 Acellular Dermal Matrices Market Challenges
11.4 Acellular Dermal Matrices Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
